MagtraceTM and Sentimag(R) Magnetic Locatization System

Lymph Node Location System During Sentinel Biopsy Procedure

FDA Premarket Approval P160053 S003

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Storing the subject product at a new storage site in endomagnetics ltd. In cambridge, united kingdom.

DeviceMagtraceTM and Sentimag(R) Magnetic Locatization System
Classification NameLymph Node Location System During Sentinel Biopsy Procedure
Generic NameLymph Node Location System During Sentinel Biopsy Procedure
ApplicantENDOMAGNETICS LTD.
Date Received2018-11-26
Decision Date2018-12-28
PMAP160053
SupplementS003
Product CodePUV
Docket NumberPremarket Approval (PMA) // Quick Links: Skip To Main Page Content Skip To Search Skip To Topics Menu Skip To Common Links U.S. Food & Drug Administration   Follow FDA En Español Search FDA   Home Food Drugs Medical Devices Radia
Advisory CommitteeGeneral & Plastic Surgery
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product Yes
Applicant Address ENDOMAGNETICS LTD. the Jeffreys Building, Cowley Road cambridge CB4 O

Supplemental Filings

Supplement NumberDateSupplement Type
P160053Original Filing
S005 2022-03-24 Normal 180 Day Track
S004 2021-04-01 Normal 180 Day Track No User Fee
S003 2018-11-26 30-day Notice
S002
S001 2018-07-30 Real-time Process

NIH GUDID Devices

Device IDPMASupp
15060391210244 P160053 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.